Literature DB >> 27062093

Diabetic retinopathy in pregnancy: a review.

Julie L Morrison1,2, Lauren Ab Hodgson1,2, Lyndell L Lim1,2,3, Salmaan Al-Qureshi1,2,3.   

Abstract

The prevalence of diabetes in pregnancy is increasing. Pre-existing diabetes is present in 1 in 167 pregnancies in Australia, divided equally between type 1 and type 2 diabetes. Diabetic retinopathy is a leading cause of blindness in women during their childbearing years, and pregnancy increases the short-term risk of diabetic retinopathy progression. We examine the risk factors for progression of diabetic retinopathy during pregnancy including duration of diabetes, baseline level of retinopathy, level of glycaemic control and hypertension. We also examine current screening and management guidelines and their levels of evidence, current treatment options for diabetic retinopathy and avenues for further research.
© 2016 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  diabetic retinopathy; pre-existing diabetes; pregnancy; prevalence

Mesh:

Year:  2016        PMID: 27062093     DOI: 10.1111/ceo.12760

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  19 in total

1.  Mode of Delivery in the Setting of Repeated Vitreous Hemorrhages in Proliferative Diabetic Retinopathy: A Case Report and Review of the Literature.

Authors:  Ahmed M Abdelaal; Abdullah S Alqahtani
Journal:  Cureus       Date:  2020-10-29

2.  Maternal disability and risk for pregnancy, delivery, and postpartum complications: a systematic review and meta-analysis.

Authors:  Lesley A Tarasoff; Saranyah Ravindran; Hannan Malik; Dinara Salaeva; Hilary K Brown
Journal:  Am J Obstet Gynecol       Date:  2019-07-12       Impact factor: 8.661

3.  Global Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Women With Preexisting Diabetes: A Systematic Review and Meta-analysis.

Authors:  Felicia Widyaputri; Sophie L Rogers; Rathika Kandasamy; Alexis Shub; Robert C A Symons; Lyndell L Lim
Journal:  JAMA Ophthalmol       Date:  2022-05-01       Impact factor: 8.253

Review 4.  Intravitreal anti-vascular endothelial growth factor medications during pregnancy: current perspective.

Authors:  Morteza Naderan; Masomeh Sabzevary; Keivan Rezaii; Ali Banafshehafshan; Seddigheh Hantoushzadeh
Journal:  Int Ophthalmol       Date:  2020-10-12       Impact factor: 2.031

5.  Analysis of the efficacy and safety of Danshen Dripping pills on the eyes of diabetic retinopathy patients with Qi stagnation and blood stasis.

Authors:  Fei Wang; Lianlian Li; Huizhen Xiao
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 6.  An overview of the management of diabetes from pre-conception, during pregnancy and in the postnatal period.

Authors:  Chloe Broughton; Isy Douek
Journal:  Clin Med (Lond)       Date:  2019-09       Impact factor: 5.410

Review 7.  Ocular changes during pregnancy.

Authors:  Mohammad Naderan
Journal:  J Curr Ophthalmol       Date:  2018-01-03

8.  Macular choroidal thickness in pregnant women with type 1, type 2 and gestational diabetes mellitus measured by spectral-domain optical coherence tomography.

Authors:  Camila Zanella Benfica; Teresinha Zanella; Lucas Brandolt Farias; Maria Lúcia Rocha Oppermann; Luis Henrique Santos Canani; Daniel Lavinsky
Journal:  Clin Ophthalmol       Date:  2018-07-17

9.  Glucose-induced microRNA-218 suppresses the proliferation and promotes the apoptosis of human retinal pigment epithelium cells by targeting RUNX2.

Authors:  Rui Yao; Xiaoxi Yao; Ru Liu; Jingli Peng; Tao Tian
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

Review 10.  The Benefits of Flavonoids in Diabetic Retinopathy.

Authors:  Ana L Matos; Diogo F Bruno; António F Ambrósio; Paulo F Santos
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.